RR6
RR6 is a potent, selective, reversible, competitive and orally active vanin inhibitor with an IC50 of 540 nM for recombinant vanin-1. RR6 also potently inhibits human, bovine and rat serum pantetheinase with IC50 values of 40 nM, 41 nM and 87 nM, respectively[1].
Product Specifications
CAS Number
1351758-37-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Pantetheinase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/RR6.html
Purity
99.65
Solubility
DMSO : ≥ 100 mg/mL
Smiles
CC(C)(CO)[C@@H](O)C(NCCC(CC1=CC=CC=C1)=O)=O
Molecular Formula
C16H23NO4
Molecular Weight
293.36
Precautions
H302, H315, H319, H335
References & Citations
[1]Jansen PA et al. Discovery of small molecule vanin inhibitors: new tools to study metabolism and disease. ACS Chem Biol. 2013 Mar 15;8 (3) :530-4.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
EWSR1 (Ewing Sarcoma Breakpoint Region 1, EWS) (APC)
